Compare RSSS & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSSS | XTNT |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 82.6M |
| IPO Year | N/A | N/A |
| Metric | RSSS | XTNT |
|---|---|---|
| Price | $2.85 | $0.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $1.50 |
| AVG Volume (30 Days) | 39.0K | ★ 183.1K |
| Earning Date | 02-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | 0.01 |
| Revenue | $49,325,684.00 | ★ $133,083,000.00 |
| Revenue This Year | $4.92 | $15.08 |
| Revenue Next Year | $7.09 | N/A |
| P/E Ratio | $73.42 | ★ $54.90 |
| Revenue Growth | 5.83 | ★ 16.88 |
| 52 Week Low | $2.32 | $0.34 |
| 52 Week High | $4.12 | $0.95 |
| Indicator | RSSS | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 36.12 |
| Support Level | $2.82 | $0.60 |
| Resistance Level | $2.94 | $0.67 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 39.10 | 5.07 |
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.